Protein-only Nanoparticles for T Cell Expansion and Activation

5Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The in vitro expansion and activation of T cells utilizing synthetic nanosized artificial antigen presenting cells (aAPCs) have emerged as a promising technique for cancer treatment. Although diverse nanomaterials have been explored as aAPC scaffolds, protein-only nanoparticles have been largely overlooked, despite their high designability and biocompatibility. In this study, we exploit a plug-and-play approach for the development of protein-only nanoparticles as aAPCs using the self-assembling properties of ZapB coiled coil and the Z-domain antibody-capturing ability. The resulting coiled coil-based nanoparticles (ccNPs) can be easily, rapidly, and simultaneously functionalized with anti-CD3 and anti-CD28 antibodies (ccNPs-CD3/CD28). Our results demonstrate that ccNPs-CD3/CD28 induce polyclonal T cell proliferation and activation while sustaining cytokine production for an extended period. The biocompatibility, modularity, and chemistry-free surface modification of this protein-only strategy render it a versatile platform for in vitro T cell expansion and activation.

Cite

CITATION STYLE

APA

Fornt-Suñé, M., Bermejo, G. L., Gil-Garcia, M., Aran, A., Garcia-Pardo, J., Martí, M., & Ventura, S. (2024). Protein-only Nanoparticles for T Cell Expansion and Activation. ACS Applied Nano Materials, 7(6), 6669–6680. https://doi.org/10.1021/acsanm.4c00698

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free